文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

I 型干扰素对抗病毒 T 细胞应答的调节作用。

Regulation of antiviral T cell responses by type I interferons.

机构信息

Institute of Microbiology, Swiss Federal Institute of Technology (ETH) Zürich, 8093 Zürich, Switzerland.

Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625 Hannover, Germany.

出版信息

Nat Rev Immunol. 2015 Apr;15(4):231-42. doi: 10.1038/nri3806. Epub 2015 Mar 20.


DOI:10.1038/nri3806
PMID:25790790
Abstract

Type I interferons (IFNs) are pro-inflammatory cytokines that are rapidly induced in different cell types during viral infections. The consequences of type I IFN signalling include direct antiviral activity, innate immune cell activation and regulation of adaptive immune responses. In this Review, we discuss recent conceptual advances in our understanding of indirect and direct regulation of T cell immunity by type I IFNs, which can either promote or inhibit T cell activation, proliferation, differentiation and survival. This regulation depends, to a large extent, on the timing of type I IFN exposure relative to T cell receptor signalling. Type I IFNs also provide activated T cells with resistance to natural killer cell-mediated elimination.

摘要

I 型干扰素(IFN)是促炎细胞因子,在病毒感染期间可迅速在不同细胞类型中诱导产生。I 型 IFN 信号转导的后果包括直接抗病毒活性、先天免疫细胞激活和适应性免疫反应的调节。在这篇综述中,我们讨论了对 I 型 IFN 间接和直接调节 T 细胞免疫的理解的最新概念进展,这些进展可以促进或抑制 T 细胞的激活、增殖、分化和存活。这种调节在很大程度上取决于 I 型 IFN 暴露相对于 T 细胞受体信号转导的时间。I 型干扰素还为激活的 T 细胞提供了对自然杀伤细胞介导的消除的抗性。

相似文献

[1]
Regulation of antiviral T cell responses by type I interferons.

Nat Rev Immunol. 2015-3-20

[2]
Induction and regulation of IFNs during viral infections.

J Interferon Cytokine Res. 2004-8

[3]
Type III IFNs: Beyond antiviral protection.

Semin Immunol. 2019-6

[4]
The role of type I interferons in intestinal infection, homeostasis, and inflammation.

Immunol Rev. 2014-7

[5]
Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Semin Immunol. 2019-5-30

[6]
Type I interferons in viral control and immune regulation.

Curr Opin Virol. 2016-2

[7]
New insights into type I interferon and the immunopathogenesis of persistent viral infections.

Curr Opin Immunol. 2015-6

[8]
Type I interferons in host defense.

Immunity. 2006-9

[9]
The role of type I interferons in CD4 T cell differentiation.

Immunol Lett. 2019-2-13

[10]
Modulation of T-cell function by type I interferon.

Immunol Cell Biol. 2012-3-6

引用本文的文献

[1]
Gene regulatory logic of the interferon-β enhancer is characterized by two selectively deployed modes of transcription factor synergy.

Proc Natl Acad Sci U S A. 2025-8-19

[2]
Eliciting antitumor immunity via therapeutic cancer vaccines.

Cell Mol Immunol. 2025-7-9

[3]
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.

bioRxiv. 2025-5-20

[4]
Heterozygous interferon signaling deficient mice as animal models for Chikungunya virus infection in the heart.

Sci Rep. 2025-5-23

[5]
The economical role of RIOK3 in modulating the Jak1/STAT1 pathway and antiviral immunity against respiratory syncytial virus infection in macrophages: implications for therapeutic potential.

Front Microbiol. 2025-4-30

[6]
CD38-targeted attenuated interferon alpha immunocytokine activates both innate and adaptive immune cells to drive anti-tumor activity.

PLoS One. 2025-5-2

[7]
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid.

Front Immunol. 2025-4-8

[8]
Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling.

Front Immunol. 2025-4-7

[9]
Plasmacytoid dendritic cell sensing of hepatitis E virus is shaped by both viral and host factors.

Life Sci Alliance. 2025-4-2

[10]
Targeted STING Activation Using Modified Ultrasound-Responsive Microbubbles Enhances Immune Checkpoint Blockade Against Melanoma.

Adv Sci (Weinh). 2025-6

本文引用的文献

[1]
NK cells regulating T cell responses: mechanisms and outcome.

Trends Immunol. 2015-1

[2]
Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses.

PLoS Pathog. 2014-9-25

[3]
IFN-α exerts opposing effects on activation-induced and IL-7-induced proliferation of T cells that may impair homeostatic maintenance of CD4+ T cell numbers in treated HIV infection.

J Immunol. 2014-9-1

[4]
OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids.

Nat Rev Immunol. 2014-7-18

[5]
Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.

Immunity. 2014-6-5

[6]
Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.

Immunity. 2014-6-5

[7]
Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Proc Natl Acad Sci U S A. 2014-6-2

[8]
Bystander chronic infection negatively impacts development of CD8(+) T cell memory.

Immunity. 2014-5-15

[9]
Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.

Proc Natl Acad Sci U S A. 2014-5-5

[10]
Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.

J Exp Med. 2014-4-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索